Company Jagsonpal Pharmaceuticals Limited

JAGSNPHARM

INE048B01027

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 12:42:30 30/04/2024 BST			5-day change	1st Jan Change
361.6 ^INR	+2.77%		+8.35%	-7.03%

03-08	Jagsonpal Pharmaceuticals Limited Launches Queezy-ER®	CI
02-02	Jagsonpal Pharmaceuticals Limited Announces Chief Financial Officer Changes	CI

Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its formulation products include Divatrone, Maintane 500 injection, Maintane 250 injection, Maintane Tablet, Indocap capsules, Metadec 50 injection, Metadec 25 injection, EndoReg Tablet, LycoRed softgels, LycoRed syrup, Doxypal DR-L Capsule, Yuliprist Tablet, COLLA-2 Tablet, Cystelia M, and DeeReg Tablet, among others. Its OTC products include Ringcuter Cream, Skin Lumia Soap-Antibacterial, and Skin Lumia Soap-Neem Tulsi. Its Naari products include Endoreg, Yuliprist, Verena, Kyrah, Krampoff, Endonorm EV2, Divagest SR 300, Divagest SR 200, Cystelia 35, Fibristone 25, and Cystelia-M. Its other products include Lycored Softgels, Lycored Syrup, JP Tone Syrup, and Doxypal DR-L. The Companyâs therapy areas include gynecology, orthopedics, and others.

Number of employees: 940

INR in Million	2022	Weight	2023	Weight	Delta
Pharmaceuticals 100.0 %	2,261	100.0 %	2,367	100.0 %	+4.70%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	2,261	100.0 %	2,367	100.0 %	+4.70%

Managers	Title	Age	Since
Manish Gupta CEO	Chief Executive Officer	-	15/07/22
Abhishek Joshi CMP	Compliance Officer	-	12/02/23
Rajpal Singh Kochhar BRD	Director/Board Member	67	16/08/78

Members of the board	Title	Age	Since
Rajpal Singh Kochhar BRD	Director/Board Member	67	16/08/78
Harsha Raghavan CHM	Chairman	52	28/06/22
Manish Gupta CEO	Chief Executive Officer	-	15/07/22
Debasis Bikash Nandy BRD	Director/Board Member	59	28/06/22
Prithipal Singh Kochhar BRD	Director/Board Member	-	28/06/22
Pallavi Dinodia Gupta BRD	Director/Board Member	43	28/06/22
Radhika Madhukar Dudhat BRD	Director/Board Member	53	28/06/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	26,437,794	8,025,905 ( 30.36 %)	0	30.36 %

Name	Equities	%	Valuation
Infinity Holdings 25.11 %	6,613,020	25.11 %	22 M ₹
Aresko Progressive Pvt Ltd. 20.25 %	5,334,254	20.25 %	18 M ₹
Infinity Holdings Sidecar I 18.06 %	4,755,300	18.06 %	16 M ₹
Rajpal Singh Kochhar 4.602 %	1,212,160	4.602 %	4 M ₹
Government of India 1.557 %	409,975	1.557 %	1 M ₹
Infinity Consumer Holdings 0.3310 %	87,180	0.3310 %	292 526 ₹
Motilal Oswal Asset Management Co. Ltd. 0.000391 %	103	0.000391 %	346 ₹

Jagsonpal Pharmaceuticals Ltd.

Nimai Tower 3rd Floor, Plot No. 412-415

122015, Gurugram

+91 12 4440 6710

http://www.jagsonpal.com

address Jagsonpal Pharmaceuticals Limited(JAGSNPHARM)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
JAGSONPAL PHARMACEUTICALS LIMITED	-7.03%	115M
ELI LILLY AND COMPANY	+33.28%	704B
NOVO NORDISK A/S	+28.59%	577B
JOHNSON & JOHNSON	-3.91%	348B
MERCK & CO., INC.	+18.30%	327B
ABBVIE INC.	+5.43%	288B
ASTRAZENECA PLC	+14.81%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-3.92%	147B

Other Pharmaceuticals